CSNK1E and breast cancer: Existing reports have shown that oral squamous cell carcinoma, breast cancer, and colorectal cancer patients with a lower expression of CSNK1E exhibited a considerably longer overall survival rate than patients with higher expression of CSNK1E [26,27,28].